Dr. Véronique Lecault is Co-founder, Chief Operating Officer and member of the Board of Directors at AbCellera. She received her PhD in Chemical and Biological Engineering from the University of British Columbia, where she co-invented the high-throughput screening platform that is now part of AbCellera’s core technology. Combining microfluidics, hyper-scale data science, machine learning, bioinformatics, and genomics, AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. Since its inception in 2012, AbCellera has grown to over 200 employees. The team has been recognized internationally, receiving three Fast Company awards in 2020, including Innovative Team of the Year. A strong advocate of entrepreneurship, science and technology, Véronique was recently recognized as a STEM Star Influencer by BCBusiness and as one of Canada’s Top 40 Under 40. She holds a B.A.Sc. in Chemical Engineering/Honours B.Sc. Biochemistry (Biotechnology) dual degree from the University of Ottawa and is a recipient of the L’Oreal-UNESCO For Women in Science Mentorship Award.